Which is better for sleep, melatonin or trazodone (an antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melatonin vs. Trazodone for Sleep: Evidence-Based Comparison

Melatonin is preferable to trazodone for sleep disorders due to its better safety profile, despite trazodone showing slightly greater efficacy in some studies. 1, 2

Efficacy Comparison

Trazodone

  • Trazodone shows greater improvement in sleep quality compared to melatonin, with significant reductions in Pittsburgh Sleep Quality Index scores in psychiatric patients (mean decrease = 7.0) 2
  • However, the American Academy of Sleep Medicine recommends against using trazodone for sleep onset or maintenance insomnia in adults, based on trials of 50 mg doses 1
  • Clinical trials showed that trazodone 50 mg produced only modest improvements in sleep parameters compared to placebo, with no improvement in subjective sleep quality 1
  • The Department of Veterans Affairs/Department of Defense (VA/DOD) guidelines explicitly advise against the use of trazodone for chronic insomnia disorder 1

Melatonin

  • Melatonin has both hypnotic and sleep/wake rhythm regulating properties that are demonstrable in healthy humans 3
  • It is particularly useful for circadian rhythm sleep disorders like delayed sleep phase syndrome, jet lag, and shift-work sleep disorder 3
  • While slightly less effective than trazodone in improving sleep quality (PSQI reduction = 6.1 vs. 7.0 for trazodone), melatonin significantly reduces daytime drowsiness 2
  • Meta-analyses have revealed that melatonin is not sufficiently effective in treating most primary sleep disorders, partly due to its extremely short half-life in circulation 3

Safety Profile Comparison

Trazodone Side Effects

  • Trazodone is associated with frequent adverse effects, including morning grogginess (15%) and orthostatic hypotension (10%) 2
  • Other adverse effects include daytime drowsiness, dizziness, and psychomotor impairment, which are particularly concerning for elderly patients 1
  • More serious risks include priapism, orthostatic hypotension, and cardiac arrhythmias 4
  • The benefits of trazodone for sleep do not outweigh the potential harms according to the American Academy of Sleep Medicine guideline 1

Melatonin Safety Advantages

  • Melatonin has the fewest adverse effects compared to trazodone, including the lowest rates of morning grogginess (5%) and dizziness (10%) 2
  • Unlike many sleep-promoting compounds, melatonin does not cause hangover nor withdrawal effects and is devoid of any addictive potential 3
  • In a hospital study comparing the two medications, melatonin showed a lower rate of patients needing additional sleep aids (19.7% vs. 34.6% for trazodone) 5

Special Populations

Elderly Patients

  • Elderly patients are at higher risk for adverse effects from sedative-hypnotics, including trazodone 4
  • Low nocturnal melatonin production and secretion have been documented in elderly insomniacs, and exogenous melatonin has been shown to be beneficial in treating sleep disturbances in these patients 3

Patients with Dementia

  • For patients with dementia and sleep disturbances, low-certainty evidence suggests that trazodone 50 mg may improve total nocturnal sleep time (42.46 minutes increase) and sleep efficiency (8.53% improvement) 6
  • However, there is low-certainty evidence that melatonin doses up to 10 mg may have little or no effect on major sleep outcomes in people with Alzheimer's disease and sleep disturbances 6

Clinical Decision Algorithm

  1. First-line approach: Cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment for chronic insomnia 1

  2. If pharmacological intervention is needed:

    • For patients with circadian rhythm disorders: Choose melatonin 3
    • For patients with primary insomnia without comorbidities: Choose melatonin due to better safety profile 1, 2
    • For patients with comorbid depression: Consider trazodone only if benefits outweigh risks 1
    • For elderly patients or those at risk for falls: Strongly prefer melatonin over trazodone 4, 1
  3. Dosing considerations:

    • Melatonin: Start with 1-3 mg taken 1-2 hours before bedtime 3
    • Trazodone (if used despite recommendations against it): Lower doses (25-50 mg) are typically employed for insomnia, which are below the therapeutic antidepressant range 1

Important Caveats

  • The American College of Physicians recommends that clinicians use a shared decision-making approach when considering pharmacological therapy for chronic insomnia disorder in whom cognitive behavioral therapy for insomnia alone was unsuccessful 4
  • Benzodiazepines and newer generation nonbenzodiazepine benzodiazepine receptor agonists (e.g., zolpidem, zaleplon, eszopiclone) have shorter half-lives and fewer overall side effects than trazodone, but high-quality data to support their use with demented older adults are nonexistent 4
  • All hypnotic medications should be administered at the lowest effective dose and for the shortest possible duration 1

References

Guideline

Trazodone for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melatonergic drugs in clinical practice.

Arzneimittel-Forschung, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacotherapies for sleep disturbances in dementia.

The Cochrane database of systematic reviews, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.